These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33151165)

  • 21. Fluoxetine at anorectic doses does not have properties of a dopamine uptake inhibitor.
    Fuller RW; Hemrick-Luecke SK; Snoddy HD
    J Neural Transm Gen Sect; 1994; 96(3):165-77. PubMed ID: 7826568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypothalamic microdialysis of mazindol causes anorexia with increase in synaptic serotonin in rats.
    Shimizu N; Take S; Hori T; Oomura Y
    Physiol Behav; 1991 Jan; 49(1):131-4. PubMed ID: 2017466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological analysis of a new anorexic substance: 5-hydroxy-5(4'-chlorophenyl)-2, 3-dihydro-5H-imidazo-(2, 1-a) isoindole (Mazindol).
    Gogerty JH; Penberthy C; Iorio LC; Trapold JH
    Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):285-307. PubMed ID: 1171662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin improves the weight reduction effect of mazindol in prediabetic obese Mexican subjects.
    Arguelles-Tello FA; Kammar-García A; Trejo-Jasso CA; Huerta-Cruz JC; Barranco-Garduño LM; Rocha-González HI; Reyes-García JG
    Int J Clin Pharmacol Ther; 2022 Aug; 60(8):336-345. PubMed ID: 35770520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demonstration of specific binding sites for [3H]mazindol in rat hypothalamus: correlation with the anorectic properties of phenylethylamines.
    Angel I; Paul SM
    Eur J Pharmacol; 1985 Jul; 113(1):133-4. PubMed ID: 4043206
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of the non-amphetaminergic anorexiant, mazindol, on neuronal activity and hypothalamic control of gastric acid secretion in rats.
    Shiraishi T
    Int J Obes; 1985; 9(4):285-97. PubMed ID: 3905642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antidiabetic effect of mangiferin in combination with oral hypoglycemic agents metformin and gliclazide.
    Sekar V; Mani S; Malarvizhi R; Nithya P; Vasanthi HR
    Phytomedicine; 2019 Jun; 59():152901. PubMed ID: 30981189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Location and effect of obesity on putative anorectic binding sites in the rat brain.
    Dunn-Meynell AA; Levin BE
    Obes Res; 1997 May; 5(3):201-7. PubMed ID: 9192394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemistry and pharmacology of mazindol.
    Gogerty JH; Trafold JH
    Triangle; 1976; 15(1):25-36. PubMed ID: 960214
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of an anorectic agent, AN 448 on weight reduction and plasma lipids.
    Ishikawa T; Nakaya N; Nakamura H; Goto Y
    Keio J Med; 1975 Jul; 24(3):211-8. PubMed ID: 1219154
    [No Abstract]   [Full Text] [Related]  

  • 31. (--)-threo-Chlorocitric acid: a novel anorectic agent.
    Sullivan AC; Dairman W; Triscari J
    Pharmacol Biochem Behav; 1981 Aug; 15(2):303-10. PubMed ID: 7312900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Site of action of anorectic drugs: glucoprivic- versus food deprivation-induced feeding.
    Angel I; Stivers JA; Paul SM; Crawley JN
    Pharmacol Biochem Behav; 1987 Jun; 27(2):291-7. PubMed ID: 3628443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The contribution of increased thermogenesis to the effect of anorectic drugs on body composition in mice.
    Arch JR
    Am J Clin Nutr; 1981 Dec; 34(12):2763-9. PubMed ID: 7315777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated mazindol and methamphetamine administration produces cross-sensitization to stereotyped behavior induced by these agents in rats.
    Kawakami Y; Suemaru K; Araki H; Kawasaki H; Gomita Y; Tanizaki Y
    Acta Med Okayama; 1998 Jun; 52(3):169-71. PubMed ID: 9661745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of mazindol on body weight and insulin sensitivity in severely obese patients after a very-low-calorie diet therapy.
    Nishikawa T; Iizuka T; Omura M; Kuramoto N; Miki T; Ito H; Chiba S
    Endocr J; 1996 Dec; 43(6):671-7. PubMed ID: 9075607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular actions of chronic intracerebroventricular administration of metformin in normotensive rats.
    Andersen D; Haugan K; Sørensen AM; Christensen S; Petersen JS
    Pharmacol Toxicol; 1997 Jul; 81(1):7-12. PubMed ID: 9258978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of propranolol phentolamine and pimozide on drug-induced anorexia in the mouse.
    Dobrzanski S; Doggett NS
    Psychopharmacology (Berl); 1979; 66(3):297-300. PubMed ID: 119276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of an anorectic agent (Mazindol) on control of obese diabetics.
    Sanders M; Breidahl H
    Med J Aust; 1976 Oct; 2(15):576-7. PubMed ID: 994969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anorectic efficacy of the fenfluramine/phentermine combination in rats: additivity or synergy?
    Roth JD; Rowland NE
    Eur J Pharmacol; 1999 Jun; 373(2-3):127-34. PubMed ID: 10414430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic mazindol reduces food intake in rats via suppression of meal size and meal number.
    Wellman PJ
    J Psychopharmacol; 2008 Jul; 22(5):532-5. PubMed ID: 18208906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.